Evidence map›Paper›PMID 39759970›Full record

ReviewJournal of pharmaceutical analysis2024

A holistic visualization for quality of Chinese materia medica: Structural and metabolic visualization by magnetic resonance imaging.

Jing Wu, Kai Zhong, Hongyi Yang, Peiliang Zhang, Nianjun Yu, Weidong Chen, Na Zhang, Shuangying Gui, Lan Han, Daiyin Peng

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of pharmaceutical analysis, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Studies Combining Network Pharmacology withCombinatorial chemistry & high throughput screening · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jing WuCollege of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, China.
Kai ZhongDepartment of Biomedical Engineering, Institute of Advanced Clinical Medicine, Peking University, Beijing, 100191, China.
Hongyi YangHefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230012, China.
Peiliang ZhangCollege of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, China.
Nianjun YuCollege of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, China.
Weidong ChenCollege of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, China.
Na ZhangHefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230012, China.
Shuangying GuiCollege of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, China.
Lan HanCollege of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, China.
Daiyin PengCollege of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The quality of Chinese materia medica (CMM) is a challenging and focused topic in the modernization of traditional Chinese medicine (TCM). A profound comprehension of the morphology, structure, active constituents, and dynamic changes during the whole process of CMM growth is essential, which needs highly precise contemporary techniques for in-depth elucidation. Magnetic resonance imaging (MRI) is a cutting-edge tool integrating the benefits of both nuclear magnetic resonance (NMR) spectroscopy and imaging technology. With real-time, non-destructive, and

Indexed as

Chinese materia medicaMagnetic resonance imagingQualityStructure and metabolitesVisualization

Identifiers

PMID39759970
PMCPMC11696849

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.